Citizens Maintains Market Outperform on Omada Health, Raises Price Target to $27
Benzinga Newsdesk 3 months ago
Analyst RatingsNewsPrice Target
Citizens analyst Constantine Davides maintains Omada Health (NASDAQ:OMDA) with a Market Outperform and raises the price target from $21 to $27.
Citizens analyst Constantine Davides maintains Omada Health (NASDAQ:OMDA) with a Market Outperform and raises the price target from $21 to $27.